Referred to the House Committee on Energy and Commerce.
This resolution expresses the House's support for recognizing the first week of June as Hidradenitis Suppurativa Awareness Week and lists goals such as raising awareness, improving diagnosis, and supporting research and access to care. It is a simple House resolution that is non-binding and does not create new laws or require federal agencies to take action. If adopted by the House, it records the chamber's view and encourages attention to the condition but does not change federal policy or spending.
This non‑binding House resolution expresses support for designating the first week of June as “Hidradenitis Suppurativa Awareness Week.” It highlights HS as a chronic inflammatory skin disease, calls for increased awareness, earlier diagnosis, research into treatments, expanded access to therapies, culturally competent care, and policies addressing disparities.
The resolution notes high unmet need, mental health impacts, and limited FDA‑approved biologic therapies.
It does not appropriate funds or create new federal programs.
As a House resolution (nonbinding), it does not create law; symbolic recognition is easy in-chamber but will not become statutory law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the public-health issue and designates an awareness week while making nonbinding statements of support for awareness, diagnosis, research, access, and policy attention.
Supporters want follow‑up funding and affordability measures; conservatives worry about mandates
These are examples from the analysis, not a ranked list of the most-affected groups.
Supporters want follow‑up funding and affordability measures; conservatives worry about mandates
Strongly supportive.
Sees the resolution as a necessary step to reduce stigma, push for research funding, and address disparities in care.
Will view recognition as an opportunity to advocate for expanded access and affordability of treatments.
Generally supportive but pragmatic.
Views the resolution as a low‑cost, bipartisan awareness measure that could justify targeted research or screening initiatives if followed by concrete proposals and cost analyses.
Cautiously supportive of awareness but wary of policy implications.
Accepts symbolic recognition but is concerned about calls for federal policy roles that could lead to mandates, higher costs, or expanded federal programs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House resolution (nonbinding), it does not create law; symbolic recognition is easy in-chamber but will not become statutory law.
The bill has not accumulated any surfaced votes yet.
Supporters want follow‑up funding and affordability measures; conservatives worry about mandates
As a House resolution (nonbinding), it does not create law; symbolic recognition is easy in-chamber but will not become statutory law.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the public-health issue and designates an awareness week while making nonbinding statements of supp…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.